leisure time -WSS

leisure time

author：Wikipedia 2025-09-05 11:31:28 - browse：9941

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： With psoriasis trial ahead, Alumis raises $259 million

WSS

Just how do doctors, lawmakers, and the public define abortion?

Wearables generate powerful data but its not useful to doctors, yet

Addiction experts warn against a second 'war on drugs'

IVF, abortion rights issues kick off Biden’s State of the Union

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Readers respond to H5N1 and livestock movements, and more

hotspot

leisure time

explore

United colonoscopy coverage change 'may cost lives,' doctors say

The drug industry has found itself all alone in Washington

BioMarin wins approval for gene therapy to treat hemophilia A

HIV vaccine remains elusive. Immunologists keep trying new ideas

Medical leaders decry Supreme Court decision on affirmative action

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Novo Nordisk obesity pill bests Wegovy in early trial

Supreme Court strikes down use of affirmative action

What it’s like to watch children die of measles

focus

Addiction experts warn against a second 'war on drugs'

Solving academic medical centers' existential crisis

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

It's time to retire 'poor historian' from clinicians' vocabularies

NEJM study link tiny plastics in blood vessels to heart problems

focus

focus

knowledge

focus